149 related articles for article (PubMed ID: 19685117)
1. Interaction between midazolam and epibatidine in spinally mediated antinociception in rats.
Nishiyama T
J Anesth; 2009; 23(3):370-7. PubMed ID: 19685117
[TBL] [Abstract][Full Text] [Related]
2. Interaction between midazolam and serotonin in spinally mediated antinociception in rats.
Nishiyama T
J Anesth; 2009; 23(2):249-55. PubMed ID: 19444565
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
Caban AJ; Hama AT; Lee JW; Sagen J
Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
[TBL] [Abstract][Full Text] [Related]
4. The synergistic interaction between midazolam and clonidine in spinally-mediated analgesia in two different pain models of rats.
Nishiyama T; Hanaoka K
Anesth Analg; 2001 Oct; 93(4):1025-31. PubMed ID: 11574377
[TBL] [Abstract][Full Text] [Related]
5. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
[TBL] [Abstract][Full Text] [Related]
6. Midazolam can potentiate the analgesic effects of intrathecal bupivacaine on thermal- or inflammatory-induced pain.
Nishiyama T; Hanaoka K
Anesth Analg; 2003 May; 96(5):1386-1391. PubMed ID: 12707139
[TBL] [Abstract][Full Text] [Related]
7. Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists.
Khan IM; Buerkle H; Taylor P; Yaksh TL
Neuropharmacology; 1998 Dec; 37(12):1515-25. PubMed ID: 9886674
[TBL] [Abstract][Full Text] [Related]
8. The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the alpha4 nicotinic receptor agonist epibatidine.
Cucchiaro G; Chaijale N; Commons KG
J Pharmacol Exp Ther; 2005 Apr; 313(1):389-94. PubMed ID: 15608080
[TBL] [Abstract][Full Text] [Related]
9. Spinally mediated analgesia and receptor binding affinity of epibatidine analogs.
Nishiyama T; Gyermek L; Trudell ML; Hanaoka K
Eur J Pharmacol; 2003 May; 470(1-2):27-31. PubMed ID: 12787827
[TBL] [Abstract][Full Text] [Related]
10. Interaction between a NMDA receptor antagonist, AP-5 and an AMPA receptor antagonist, YM 872 in antinociception in the spinal cord.
Nishiyama T
Acta Anaesthesiol Scand; 2008 Apr; 52(4):493-8. PubMed ID: 18339155
[TBL] [Abstract][Full Text] [Related]
11. Analgesic interaction between intrathecal midazolam and glutamate receptor antagonists on thermal-induced pain in rats.
Nishiyama T; Gyermek L; Lee C; Kawasaki-Yatsugi S; Yamaguchi T
Anesthesiology; 1999 Aug; 91(2):531-7. PubMed ID: 10443617
[TBL] [Abstract][Full Text] [Related]
12. The antinociceptive effect of intrathecal administration of epibatidine with clonidine or neostigmine in the formalin test in rats.
Hama AT; Lloyd GK; Menzaghi F
Pain; 2001 Mar; 91(1-2):131-8. PubMed ID: 11240085
[TBL] [Abstract][Full Text] [Related]
13. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain.
Kesingland AC; Gentry CT; Panesar MS; Bowes MA; Vernier JM; Cube R; Walker K; Urban L
Pain; 2000 May; 86(1-2):113-8. PubMed ID: 10779668
[TBL] [Abstract][Full Text] [Related]
14. Analgesic effects of systemic midazolam: comparison with intrathecal administration.
Nishiyama T
Can J Anaesth; 2006 Oct; 53(10):1004-9. PubMed ID: 16987855
[TBL] [Abstract][Full Text] [Related]
15. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats.
Curzon P; Nikkel AL; Bannon AW; Arneric SP; Decker MW
J Pharmacol Exp Ther; 1998 Dec; 287(3):847-53. PubMed ID: 9864263
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive properties of propofol: involvement of spinal cord gamma-aminobutyric acid(A) receptors.
Nadeson R; Goodchild CS
J Pharmacol Exp Ther; 1997 Sep; 282(3):1181-6. PubMed ID: 9316824
[TBL] [Abstract][Full Text] [Related]
17. The locus coeruleus nucleus as a site of action of the antinociceptive and behavioral effects of the nicotinic receptor agonist, epibatidine.
Cucchiaro G; Chaijale N; Commons KG
Neuropharmacology; 2006 Jun; 50(7):769-76. PubMed ID: 16460769
[TBL] [Abstract][Full Text] [Related]
18. Antihyperalgesic activity of epibatidine in the formalin model of facial pain.
Gilbert SD; Clark TM; Flores CM
Pain; 2001 Jan; 89(2-3):159-65. PubMed ID: 11166471
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic cholinergic receptors: potential targets for inflammatory pain relief.
Lawand NB; Lu Y; Westlund KN
Pain; 1999 Mar; 80(1-2):291-9. PubMed ID: 10204742
[TBL] [Abstract][Full Text] [Related]
20. The antinociceptive effect of SNAP5114, a gamma-aminobutyric acid transporter-3 inhibitor, in rat experimental pain models.
Kataoka K; Hara K; Haranishi Y; Terada T; Sata T
Anesth Analg; 2013 May; 116(5):1162-1169. PubMed ID: 23456665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
